This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.

Unlock the details of this groundbreaking opportunity here...

John Kleckner Biography and Net Worth

Insider of Enovis

Presently, John Kleckner occupies the position of Chief Accounting Officer at Enovis Corp.

He previously was Senior Director & Controller at MEDHOST of Tennessee, Inc.

Mr. Kleckner received an undergraduate degree and a graduate degree from Baylor University.

What is John Kleckner's net worth?: The estimated net worth of John Kleckner is at least $231,062.04 as of August 7th, 2023. Mr. Kleckner owns 4,218 shares of Enovis stock worth more than $231,062 as of April 25th. This net worth estimate does not reflect any other assets that Mr. Kleckner may own. Learn More about John Kleckner's net worth.
How old is John Kleckner?: Mr. Kleckner is currently 47 years old. There are 7 older executives and no younger executives at Enovis. The oldest executive at Enovis is Ms. Patricia A. Lang, Senior VP & Chief Human Resources Officer, who is 65 years old. Learn More on John Kleckner's age.
How do I contact John Kleckner?: The corporate mailing address for Mr. Kleckner and other Enovis executives is 2711 Centerville Road Suite 400, Wilmington DE, 19808. Enovis can also be reached via phone at 302-252-9160 and via email at [email protected]. Learn More on John Kleckner's contact information.
Has John Kleckner been buying or selling shares of Enovis?: John Kleckner has not been actively trading shares of Enovis within the last three months. Most recently, John Kleckner sold 174 shares of the business's stock in a transaction on Monday, August 7th. The shares were sold at an average price of $59.18, for a transaction totalling $10,297.32. Following the completion of the sale, the insider now directly owns 4,218 shares of the company's stock, valued at $249,621.24. Learn More on John Kleckner's trading history.
Who are Enovis' active insiders?: Enovis' insider roster includes Benjamin Berry (CFO), Christopher Hix (CFO), John Kleckner (Insider), Patricia Lang (SVP), A. Perfall (Director), Daniel Pryor (EVP), Brady Shirley (COO), Bradley Tandy (SVP), Matthew Trerotola (CEO), and Rajiv Vinnakota (Director). Learn More on Enovis' active insiders.
Are insiders buying or selling shares of Enovis?: During the last year, insiders at the sold shares 4 times. They sold a total of 2,282 shares worth more than $129,436.69. The most recent insider tranaction occured on August, 7th when insider John Kleckner sold 174 shares worth more than $10,297.32. Insiders at Enovis own 2.4% of the company. Learn More about insider trades at Enovis.
Information on this page was last updated on 8/7/2023.

John Kleckner Insider Trading History at Enovis

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/7/2023	Sell	174	$59.18	$10,297.32	4,218
7/20/2023	Sell	67	$65.32	$4,376.44	4,392
2/21/2023	Sell	134	$61.45	$8,234.30	2,342
7/20/2022	Sell	44	$56.73	$2,496.12	1,661

John Kleckner Buying and Selling Activity at Enovis

Enovis Company Overview

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.

Today's Range

Now: $55.07

$54.69

$55.93

50 Day Range

MA: $60.04

$55.29

$63.80

2 Week Range

Now: $55.07

$43.04

$66.14

Volume

351,298 shs

Average Volume

457,484 shs

Market Capitalization

$3.02 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.97

Jim Cramer’s “The Biggest Drug Ever”

From Behind the Markets | Ad